在干预和治疗前预测需要高级呼吸支持的急性呼吸衰竭:基于电子病历数据的多变量预测模型
该研究利用埃默里医疗网络2014年1月至2017年6月三家医院82,699次入院记录推导模型,用第四家医院40,143次入院记录进行外部验证,并用2020年2月至4月四家医院2,564次COVID-19检测和389次COVID-19阳性入院记录进行时间验证。模型预测需任何高级呼吸支持(包括无创通气)的急性呼吸衰竭,其区分度优于改良早期预警评分(测试集AUC 0.85 vs 0.57,外部验证0.84 vs 0.61)。模型在保持与改良早期预警评分>4相似阳性预测值的同时,识别出6.62至9.58倍的真阳性。作者结论认为该模型在外部验证和COVID-19患者中比改良早期预警评分更有效,但部署前需 silent 前瞻性验证。
要点
- 模型预测需任何高级呼吸支持(包括无创通气)的急性呼吸衰竭,测试集AUC 0.85 vs 改良早期预警评分0.57,外部验证0.84 vs 0.61。
- 模型阳性预测值0.31-0.21,与改良早期预警评分>4的0.29-0.25相似,但真阳性识别数多6.62倍(验证)至9.58倍(测试)。
- 时间验证中模型AUC为0.86(COVID-19检测人群)和0.93(COVID-19阳性人群),真阳性识别数多4.25-4.51倍。
- 排除标准包括手术室内开始有创机械通气或入院8小时内接受高级呼吸支持。
- 作者结论:外部验证和COVID-19患者中模型优于改良早期预警评分,但本地部署前需 silent 前瞻性验证。
适用人群与场景
- 推导队列:2014年1月至2017年6月埃默里医疗网络三家医院的所有入院记录(82,699次)。
- 外部验证队列:2014年1月至2017年6月埃默里医疗网络第四家医院的所有入院记录(40,143次)。
- 时间验证队列:2020年2月至4月埃默里医疗网络四家医院COVID-19检测人群(2,564次)和COVID-19阳性人群(389次)。
- 排除标准:手术室内开始有创机械通气或入院8小时内接受高级呼吸支持。
诊断标准与关键阈值
- 预测目标:需任何高级呼吸支持(包括无创通气)的急性呼吸衰竭。
- 入院8小时后至出院或高级呼吸支持启动,按小时区间离散化并二分类标记是否接受高级呼吸支持。
研究设计与关键结果
- 研究类型:多变量预测模型开发与验证研究,使用电子病历数据。
- 推导队列82,699次入院记录,外部验证队列40,143次入院记录,时间验证队列包括COVID-19检测人群2,564次和COVID-19阳性人群389次入院记录。
- 模型(eXtreme Gradient Boosting算法)与改良早期预警评分比较,测试集AUC 0.85 vs 0.57,外部验证AUC 0.84 vs 0.61。
- 模型阳性预测值0.31-0.21,改良早期预警评分>4阳性预测值0.29-0.25,模型真阳性识别数为改良早期预警评分的6.62倍(验证)至9.58倍(测试)。
- 时间验证中模型AUC为0.86(COVID-19检测人群)和0.93(COVID-19阳性人群),真阳性识别数多4.25-4.51倍。
证据类型、等级与局限
- 证据类型:多变量预测模型的推导与验证研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,该模型在外部验证和COVID-19患者中预测需高级呼吸支持的急性呼吸衰竭比改良早期预警评分更有效。
- 作者指出,本地部署前需 silent 前瞻性验证。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute respiratory failure occurs frequently in hospitalized patients and often begins outside the ICU, associated with increased length of stay, cost, and mortality. Delays in decompensation recognition are associated with worse outcomes.
OBJECTIVES: The objective of this study is to predict acute respiratory failure requiring any advanced respiratory support (including noninvasive ventilation). With the advent of the coronavirus disease pandemic, concern regarding acute respiratory failure has increased.
DERIVATION COHORT: All admission encounters from January 2014 to June 2017 from three hospitals in the Emory Healthcare network (82,699).
VALIDATION COHORT: External validation cohort: all admission encounters from January 2014 to June 2017 from a fourth hospital in the Emory Healthcare network (40,143). Temporal validation cohort: all admission encounters from February to April 2020 from four hospitals in the Emory Healthcare network coronavirus disease tested (2,564) and coronavirus disease positive (389).
PREDICTION MODEL: All admission encounters had vital signs, laboratory, and demographic data extracted. Exclusion criteria included invasive mechanical ventilation started within the operating room or advanced respiratory support within the first 8 hours of admission. Encounters were discretized into hour intervals from 8 hours after admission to discharge or advanced respiratory support initiation and binary labeled for advanced respiratory support. Prediction of Acute Respiratory Failure requiring advanced respiratory support in Advance of Interventions and Treatment, our eXtreme Gradient Boosting-based algorithm, was compared against Modified Early Warning Score.
RESULTS: Prediction of Acute Respiratory Failure requiring advanced respiratory support in Advance of Interventions and Treatment had significantly better discrimination than Modified Early Warning Score (area under the receiver operating characteristic curve 0.85 vs 0.57 [test], 0.84 vs 0.61 [external validation]). Prediction of Acute Respiratory Failure requiring advanced respiratory support in Advance of Interventions and Treatment maintained a positive predictive value (0.31-0.21) similar to that of Modified Early Warning Score greater than 4 (0.29-0.25) while identifying 6.62 (validation) to 9.58 (test) times more true positives. Furthermore, Prediction of Acute Respiratory Failure requiring advanced respiratory support in Advance of Interventions and Treatment performed more effectively in temporal validation (area under the receiver operating characteristic curve 0.86 [coronavirus disease tested], 0.93 [coronavirus disease positive]), while achieving identifying 4.25-4.51× more true positives.
CONCLUSIONS: Prediction of Acute Respiratory Failure requiring advanced respiratory support in Advance of Interventions and Treatment is more effective than Modified Early Warning Score in predicting respiratory failure requiring advanced respiratory support at external validation and in coronavirus disease 2019 patients. Silent prospective validation necessary before local deployment.
参考来源
- Wong AI, Kamaleswaran R, Tabaie A, et al. Prediction of Acute Respiratory Failure Requiring Advanced Respiratory Support in Advance of Interventions and Treatment: A Multivariable Prediction Model From Electronic Medical Record Data. Crit Care Explor. 2021. PMID: 34079945. doi:10.1097/CCE.0000000000000402
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。